RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.40

EPS Forecast

$139.1

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31

Market expectations

EPS Expectation:

-$1.40

Revenue Expectation:

$139.1

EPS Surprise Expectation:

$0.050

Revenue Surprise Expectation:

$5

Post-release price volatility - High

Post-release Overnight Move:

±7.0%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: